Cellcept Used To Prevent The Rejection Of Organ Transplants - Pillsformedicine

By Author: Anna Austen
Total Articles: 28
Comment this article

It is indicated in combination with cyclosporine and corticosteroids for the prophylaxis of acute transplant rejection in patients receive allergenic renal, cardiac or hepatic transplants. Mycophenolate mofetil is the 2-morpholinoethyl ester of MPA. MPA is a potent, selective, uncompetitive and reversible inhibitor of in sine monophosphate dehydrogenises, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are acutely dependent for their proliferation on de novo synthesis of p urines whereas other cell types can utilize salvage pathways, MPA has more potent cytostatic effects on lymphocytes than on other cells.
Dosage :
Oral CellCept should be initiated within 72 hours following transplantation. The dose in renal transplant is 1 g administered twice daily (2 g daily dose). It should only be agreed to a person whose body surface area greater than 1.5 m2, ...
... at a dose of 1 g twice daily (2 g daily dose). Oral CellCept should be initiated within 5 days following transplantation. The recommended dose in cardiac transplant patients is 1.5 g administered twice daily (3 g daily dose).It should be administered for the first 4 days following hepatic transplant, with oral It initiated as soon after this as it can be tolerated. The recommended oral dose in hepatic transplant patients is 1.5 g administered twice daily (3 g daily dose).

Precaution:

To minimize the risk of skin cancer, avoid exposure to sunlight and UV light should be limited by wearing protective clothing and using a sunscreen with a high protection factor (HPF).
Report immediately if you found any indication of infection like sudden bruising, bleeding or any other symptom of bone marrow depression.
Infections like bacterial, fungal, viral and protozoal, fatal infections and sepsis. Such infections include latent viral reactivation, such as hepatitis B or hepatitis C reactivation and infections caused by polyoma viruses
Patients receiving it should be monitored for neutropenia, which may be related to itself, concomitant medications, viral infections, or some combination of these causes. Patients taking it should have complete blood counts weekly during the first month, twice monthly for the second and third months of treatment, then monthly through the first year.

Side Effects:

Combination of cyclosporine and corticosteroids include diarrhea, leucopenia, sepsis and vomiting, and there is evidence of a higher frequency of certain types of infections.
Serious infections like meningitis, endocarditis, tuberculosis and a usual mycobacterial infection.
Pure red cell aplasia (PRCA) has been reported in patients treated with it.
Hypersensitivity reactions.
Diarrhea, sepsis, leucopenia, anemia and infection reported in children less than 6 years of age.
Elderly patients have risk of bad reactions due to immune suppression of certain infections including cytomegalovirus tissue invasive disease and possibly gastrointestinal haemorrhage and pulmonary oedema, compared to younger individuals.
This has been reported aplastic anemia and bone marrow depression in patients treated with it, some of which have been critical.
It will also report pure red cell aplasia (PRCA).
Hypersensitivity reactions, including angioneurotic oedema and anaphylactic reaction have been reported.

Storage:

Do not store above 30 °C. Keep the blister in the outer carton in order to protect from light.

Hi Friends, this is Anna Austen form Australia. I am completed P. HD in phamacy. Now i am working in pillsformedicine.com. I have lot of experience in medicines field. I also write blog on human health related product. Like CellCept online in Australia, Xyzal, Order Zithromax online in Australia, Vitamin C, etc.